Joel Ackerman Biography and Net Worth

CFO of DaVita

Joel Ackerman joined the board of One Acre Fund in 2008, and became Board Chairman in 2009. Prior to joining DaVita, he served as CEO of Champions Oncology from 2010-2017. Ackerman was also previously a partner at Warburg Pincus, a leading global private equity firm. Joel spent more than 15 years at Warburg Pincus, most recently as the head of the healthcare services group and a member of the executive management committee. Prior to Warburg Pincus, Joel spent three years working at Mercer Management Consulting. He currently sits on the board of directors of Kindred Healthcare Inc. and previously served on the board of Coventry Health Care Inc., both publicly traded healthcare service companies. He graduated summa cum laude and Phi Beta Kappa from Columbia University with a BA in physics. He also received an MA in physics from Harvard University.

Joel is an independent voting member of the board.

What is Joel Ackerman's net worth?: The estimated net worth of Joel Ackerman is at least $17.99 million as of August 27th, 2024. Mr. Ackerman owns 111,481 shares of DaVita stock worth more than $17,993,033 as of November 21st. This net worth estimate does not reflect any other assets that Mr. Ackerman may own. Additionally, Mr. Ackerman receives an annual salary of $1,190,000.00 as CFO at DaVita. Learn More about Joel Ackerman's net worth.
How old is Joel Ackerman?: Mr. Ackerman is currently 59 years old. There are 6 older executives and no younger executives at DaVita. Learn More on Joel Ackerman's age.
What is Joel Ackerman's salary?: As the CFO of DaVita Inc., Mr. Ackerman earns $1,190,000.00 per year. There are 2 executives that earn more than Mr. Ackerman. The highest earning executive at DaVita is Mr. Javier J. Rodriguez, CEO & Executive Director, who commands a salary of $2,980,000.00 per year. Learn More on Joel Ackerman's salary.
How do I contact Joel Ackerman?: The corporate mailing address for Mr. Ackerman and other DaVita executives is 2000 16TH STREET, DENVER CO, 80202. DaVita can also be reached via phone at (720) 631-2100 and via email at [email protected]. Learn More on Joel Ackerman's contact information.
Has Joel Ackerman been buying or selling shares of DaVita?: Joel Ackerman has not been actively trading shares of DaVita during the last quarter. Most recently, Joel Ackerman sold 64,029 shares of the business's stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $155.06, for a transaction totalling $9,928,336.74. Following the completion of the sale, the chief financial officer now directly owns 111,481 shares of the company's stock, valued at $17,286,243.86. Learn More on Joel Ackerman's trading history.
Who are DaVita's active insiders?: DaVita's insider roster includes Joel Ackerman (CFO), Pamela Arway (Director), Charles Berg (Director), Barbara Desoer (Director), Paul Diaz (Director), James Hearty (Chief Compliance Officer), John Nehra (Director), Paula Price (Director), Javier Rodriguez (CEO), Michael Staffieri (COO), Kathleen Waters (Insider), and Phyllis Yale (Director). Learn More on DaVita's active insiders.
Are insiders buying or selling shares of DaVita?: In the last year, insiders at the sold shares 11 times. They sold a total of 313,052 shares worth more than $44,636,354.33. The most recent insider tranaction occured on September, 16th when CEO Javier Rodriguez sold 50,000 shares worth more than $8,252,500.00. Insiders at DaVita own 2.0% of the company. Learn More about insider trades at DaVita.
Information on this page was last updated on 9/16/2024.

Joel Ackerman Insider Trading History at DaVita

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/27/2024	Sell	64,029	$155.06	$9,928,336.74	111,481
8/5/2021	Sell	37,760	$131.36	$4,960,153.60	35,500

Joel Ackerman Buying and Selling Activity at DaVita

DaVita Company Overview

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Today's Range

Now: $161.40

$156.86

$161.89

50 Day Range

MA: $158.14

$139.81

$165.19

2 Week Range

Now: $161.40

$97.31

$168.50

Volume

997,774 shs

Average Volume

996,926 shs

Market Capitalization

$13.23 billion

P/E Ratio

17.41

Dividend Yield

N/A

Beta

0.89

Election warning coming true…

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - watch it before it's too late.

Click here to watch it now.

Joel Ackerman Biography and Net Worth

What is Joel Ackerman's net worth?

How old is Joel Ackerman?

What is Joel Ackerman's salary?

How do I contact Joel Ackerman?

Has Joel Ackerman been buying or selling shares of DaVita?

Who are DaVita's active insiders?

Are insiders buying or selling shares of DaVita?